The Science Consortium at the 23rd International Congress of the European Society of Toxicology In Vitro

23rd International Congress of the European Society of Toxicology In Vitro (ESTIV)
29 June–2 July 2026
Maastricht, The Netherlands

Monday, 29 June

POSTER
Poster Number: P312 (PDF)
Vaginal irritation testing: towards regulatory acceptance of a method using reconstructed human vaginal epithelium
Perrin J,1 Costin GE,2 Ayehunie S,3 Brown J,1 Clippinger AJ1
1PETA Science Consortium International e.V.; 2Institute for In Vitro Sciences, Inc.; 3MatTek (Now Part of Sartorius)
Time: 18:30–20:00

Tuesday, 30 June

CHAIRED SESSION
International standards as the bridge to the future of safe medical devices (Speaker Presentations; Literature and Resources)
Time: 11:00–13:00
Co-chairs: Helena Kandarova (Institute of Experimental Pharmacology and Toxicology), Jessica Perrin (PETA Science Consortium International e.V.)
Speakers:

  • Janine Townsend (Chorley Consulting Ltd): Practical challenges to the use of NAMs for medical devices – when state-of-the-art science alone is not enough
  • Seyoum Ayehunie (MatTek, Now Part of Sartorius): NAM approach for vaginal irritation assay to evaluate irritation potential of feminine care products and medical devices
  • Kelly Coleman (Medtronic): In vitro irritation testing for medical devices: validation and regulatory acceptance
  • Shabnam Solati (MAT BioTech B.V.): Advancing medical device pyrogen testing through the in vitro monocyte activation test
  • Lindsey Borton (Gradient): Chasing phantoms? A case study on replacing the rabbit pyrogen test for the evaluation of material-mediated pyrogens in medical devices
  • Amanda Ulrey (Institute for In Vitro Sciences, Inc.): Converging efforts for the advancement of new approach methodologies in the current regulatory context: safety assessment of medical devices

POSTER
Poster Number: P311 (PDF)
Advancing human-relevant in vitro methods to assess respiratory tissue irritation
Stucki AO,1 Sharma M,1 Roldan N,1 Clippinger AJ1
1PETA Science Consortium International e.V.
Time: 18:30–19:30

Wednesday, 1 July

CHAIRED SESSION
Replacing animals in therapeutic monoclonal antibody approvals (Speaker Presentations)
Time: 09:00–10:30
Co-chairs: Jeffrey Brown (PETA Science Consortium International e.V.), Andreas Stucki (PETA Science Consortium International e.V.)
Speakers:

  • Leander Grode (Serum Life Science Europe GmbH): The current landscape of non-animal preclinical assessment for monoclonal antibodies and biopharmaceuticals
  • Jessica Perrin (PETA Science Consortium International e.V.): Approaching the development and regulatory review of therapeutic monoclonal antibodies without using animal studies
  • Esther Wenzel (Abcalis GmbH): Beyond the saddle: fully human antibodies against diphtheria toxin from animal-free discovery platforms

Thursday, 2 July

CHAIRED SESSION
Guidance for in vitro air–liquid interface inhalation toxicity assessment
Time: 09:00–11:00
Co-chairs: Tanja Hansen (Fraunhofer ITEM), Andreas Stucki (PETA Science Consortium International e.V.)
Speakers: see Session 11 Track B, ESTIV Congress 2026 program